• 8153 Citations
  • 49 h-Index
1982 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Nizar M Tannir is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 66 Similar Profiles
Renal Cell Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Nephrectomy Medicine & Life Sciences
Survival Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Kidney Medicine & Life Sciences
gemcitabine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1982 2019

8 Citations (Scopus)

A first-in-human study and biomarker analysis of NKTR-214, a novel IL2Rβγ-biased cytokine, in patients with advanced or metastatic solid tumors

Bentebibel, S. E., Hurwitz, M. E., Bernatchez, C., Haymaker, C. L., Hudgens, C. W., Kluger, H. M., Tetzlaff, M., Tagliaferri, M. A., Zalevsky, J., Hoch, U., Fanton, C., Aung, S., Hwu, P., Curti, B. D., Tannir, N. M., Sznol, M. & Diab, A., Jun 1 2019, In : Cancer discovery. 9, 6, p. 711-721 11 p.

Research output: Contribution to journalArticle

Open Access
Interleukin-2
Biomarkers
Interleukin-2 Receptors
Cytokines
Biopsy

COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma

Sternberg, C. N., Motzer, R. J., Hutson, T. E., Choueiri, T. K., Kollmannsberger, C., Bjarnason, G. A., Paul Nathan, N., Porta, C., Grünwald, V., Dezzani, L., Han, J. & Tannir, N. M., Jan 1 2019, (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Contribution to journalArticle

Open Access
Renal Cell Carcinoma
Disease-Free Survival
pazopanib
Safety
Biomarkers

Evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma of variant histology

Alhalabi, O., Karam, J. A. & Tannir, N. M., Sep 1 2019, In : Current opinion in urology. 29, 5, p. 521-525 5 p.

Research output: Contribution to journalArticle

Nephrectomy
Renal Cell Carcinoma
Histology
Immunotherapy
Therapeutics

Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma

Ruiz-Cordero, R., Rao, P., Li, L., Qi, Y., Atherton, D., Peng, B., Singh, R. R., Kim, T. B., Kawakami, F., Routbort, M. J., Alouch, N., Chow, C. W. B., Tang, X., Lu, W., Brimo, F., Matin, S. F., Wood, C. G., Tannir, N. M., Wistuba, I. I., Chen, K. & 5 others, Wang, J., Jeffrey Medeiros, L., Karam, J. A., Tamboli, P. & Sircar, K., Jan 1 2019, In : Modern Pathology.

Research output: Contribution to journalArticle

Oxyphilic Adenoma
Renal Cell Carcinoma
Kidney
Neoplasms
Renal oncocytoma

Low incidence of late failure and toxicity after spine stereotactic radiosurgery: Secondary analysis of phase I/II trials with long-term follow-up

Ning, M. S., Deegan, B. J., Ho, J. C., Chapman, B. V., Bishop, A. J., Allen, P. K., Tannir, N. M., Amini, B., Briere, T. M., Wang, X. A., Tatsui, C. E., Rhines, L. D., Brown, P. D., Li, J. & Ghia, A. J., Sep 1 2019, In : Radiotherapy and Oncology. 138, p. 80-85 6 p.

Research output: Contribution to journalArticle

Radiosurgery
Spine
Incidence
Survivors
Radiation